WCNDD Director of Outreach and Advocacy Programs, Kristen Gilliland, in the spotlight! Huge thank you to everyone who came out to the Franklin Theatre on Tuesday, August 15th to support her efforts. It was a huge success for everyone involved. Check out the full article below!
Grant aids drug discovery for autism, schizophrenia
With the aid of a four-year, $2.7 million grant from the National Institute of Mental Health, part of the National Institutes of Health (NIH), Vanderbilt University Medical Center pharmacologist Jerod Denton, PhD, and his team will pave the way for potential treatments for schizophrenia and autism spectrum disorder (ASD).
WCNDD Newsletter Vol. 1 Issue 4
Don’t miss this month’s newsletter featuring the details of the launch of the Warren Center Lecture Series kicking off in September and the highlights from the premiere screening of the “Speaking through Me” documentary. The event packed the Franklin Theatre on Tuesday, August 15th. The WCNDD Director of Outreach and Advocacy programs, Kristen Gilliland, has been all over the Nashville area, educating students and their parents on the importance of brain development in adolescents. Check out the back page for more outreach upcoming events.
Be sure to check out this month’s newsletter about our upcoming Warren Center Lecture Series, set to launch this September 2023. Unique speakers across drug discovery will be invited to present both on campus and at the WCNDD. Also featured in this newsletter is important updates about our Outreach program and special recognition to one our Senior Leaders. Be sure to follow us on social media to stay connected!
WCNDD Newsletter Volume 1 Issue 2
We are excited to share the second issue of the Warren Center for Neuroscience Drug Discovery Newsletter. There are so many wonderful things happening at the center, it’s impossible to capture them all. Be sure to stay current by following us on Twitter, LinkedIn, and Instagram.
WCNDD Executive Director, Craig Lindsley, joins CAS Life Sciences Advisory Board. The board will guide the expanded CAS drug discovery journey to empower better decisions early in the drug discovery process. Read full press release at CAS convenes life sciences advisory board to reimagine the future of scientific discovery | CAS.
